Literature DB >> 28476835

Solitary Splenic Metastasis After Surgically-treated Cervical Cancer - A Case Report and Literature Review.

Nicolae Bacalbasa1, Irina Balescu2, Madalina Marcu3, Dana Nuti Oprescu4, Alexandru Florin Anca5.   

Abstract

BACKGROUND/AIM: Solitary metastases after surgically-treated cervical cancer are a rare entity, with only few cases described so far. PATIENT AND METHODS: We present the case of a 31-year-old patient diagnosed with a tumoral splenic lesion at 18 months after surgically-treated cervical cancer.
RESULTS: The patient was submitted to surgery, with a splenectomy being performed. The histopathological studies confirmed the presence of a squamous cell cervical cancer splenic metastasis. At one year follow-up after splenectomy, the patient is free of any recurrent disease.
CONCLUSION: Solitary splenic metastases after surgically-treated cervical cancer are rarely seen; however, this diagnostic should not be omitted whenever a medical history of cervical cancer is present. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Cervical cancer; splenectomy; splenic metastasis

Mesh:

Year:  2017        PMID: 28476835     DOI: 10.21873/anticanres.11607

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Radical Hysterectomy for Cervical Cancer in Patients With Uterine Prolapse.

Authors:  Nicolae Bacalbasa; Ioana Halmaciu; Dragos Cretoiu; Cristian Balalau; Camelia Diaconu; Laura Iliescu; Gabriel Gorecki; Ciprian Bolca; Adrian Neacsu; Irina Balescu
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Splenic oligometastasis from cervical adenocarcinoma three years after disease free survival: A case report and a review of literature.

Authors:  Abdullah Saleh AlQattan; Afnan Amro Alqutub; Jumana Husain Masoudi; Maha Abdulaziz M Alassaf; Nabeel Mansi
Journal:  Ann Med Surg (Lond)       Date:  2021-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.